Sofosbuvir + velpatasvir
Y. Vivian Tsai, Pharm.D., Janessa M. Smith, PharmD, BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of pediatric patients (≥3 years old) and adult patients with chronic HCV genotype 1, 2, 3, 4, 5 or 6 without cirrhosis, or with compensated cirrhosis, or with decompensated cirrhosis in combination with ribavirin
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.